KYMR Financials
Kymera Therapeutics Inc - Financial statements & key metrics
Stock Price
$87.71
Market Cap
$7.16B
EPS
$-3.69
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$47.07M
Gross Profit
-
Operating Income
-
Net Income
$-223.86M
EPS (Diluted)
$-2.98
Balance Sheet Highlights
Total Assets
$978.03M
Total Liabilities
$142.42M
Shareholders Equity
-
Cash & Equivalents
$120.26M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-194.50M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-707.3%
Operating Margin
-34.1%
ROE
-0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KYMR revenue?
KYMR's most recent quarterly revenue was $47.07M. Annual revenue can be calculated by summing the four most recent quarters.
Is KYMR profitable?
KYMR reported a loss of $223.86M in the most recent quarter.
What is KYMR market cap?
KYMR has a market capitalization of $7.16B, making it a mid-cap stock.
Does KYMR have debt?
View KYMR's balance sheet for debt information.
What is KYMR cash flow?
Cash flow data is available in the full financial statements.